Seth Lederman
2021
In 2021, Seth Lederman earned a total compensation of $7.7M as Chief Executive Officer at Tonix Pharmaceuticals Holding, a 99% increase compared to previous year.
Compensation breakdown
| Bonus | $506,250 |
|---|---|
| Option Awards | $6,527,139 |
| Salary | $675,000 |
| Total | $7,708,389 |
Lederman received $6.5M in option awards, accounting for 85% of the total pay in 2021.
Lederman also received $506.3K in bonus and $675K in salary.
Rankings
In 2021, Seth Lederman's compensation ranked 1,519th out of 12,415 executives tracked by ExecPay. In other words, Lederman earned more than 87.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,519 out of 12,415 | 88th |
Division Manufacturing | 550 out of 5,505 | 90th |
Major group Chemicals And Allied Products | 210 out of 2,375 | 91st |
Industry group Drugs | 175 out of 2,096 | 92nd |
Industry Pharmaceutical Preparations | 120 out of 1,546 | 92nd |
Source: SEC filing on March 18, 2022.
Lederman's colleagues
We found three more compensation records of executives who worked with Seth Lederman at Tonix Pharmaceuticals Holding in 2021.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019